Literature DB >> 10573308

Active heroin injectors' perceptions and use of methadone maintenance treatment: cynical performance or self-prescribed risk reduction?

S Koester1, K Anderson, L Hoffer.   

Abstract

In addition to the numerous heroin users who voluntarily enter methadone treatment as a way to free themselves from illicit drug addiction and those ordered to do so by the courts, there are a large number of opioid users who enter methadone treatment with other objectives in mind. These include shorter-term goals that users do not necessarily equate with complete heroin abstinence. In this paper we report the results of a qualitative study designed to identify and describe the motivations active heroin users have for entering methadone treatment, and to suggest that many of these short-term methadone episodes may operate as self-prescribed attempts at risk reduction, and act as pilot tests for users considering or anticipating entering treatment to quit the use of illicit drugs. We argue that heroin users' motivations, perceptions about methadone, and the strategies they devise for adapting methadone treatment for their own needs should be recognized for their value in reducing the multiple risks associated with drug use.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10573308     DOI: 10.3109/10826089909039442

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  19 in total

Review 1.  Disciplining addictions: the bio-politics of methadone and heroin in the United States.

Authors:  P Bourgois
Journal:  Cult Med Psychiatry       Date:  2000-06

2.  Patient perspectives on buprenorphine/naloxone: a qualitative study of retention during the starting treatment with agonist replacement therapies (START) study.

Authors:  Cheryl Teruya; Robert P Schwartz; Shannon Gwin Mitchell; Albert L Hasson; Christie Thomas; Samantha H Buoncristiani; Yih-Ing Hser; Katharina Wiest; Allan J Cohen; Naomi Glick; Petra Jacobs; Paul McLaughlin; Walter Ling
Journal:  J Psychoactive Drugs       Date:  2014 Nov-Dec

3.  Punishment induces risky decision-making in methadone-maintained opiate users but not in heroin users or healthy volunteers.

Authors:  Karen D Ersche; Jonathan P Roiser; Luke Clark; Mervyn London; Trevor W Robbins; Barbara J Sahakian
Journal:  Neuropsychopharmacology       Date:  2005-11       Impact factor: 7.853

4.  Pathways of Substance Users Linking (Or Not) With Treatment.

Authors:  Cristina Redko; Richard C Rapp; Robert G Carlson
Journal:  J Drug Issues       Date:  2007

5.  The psychotropic self/imaginary: subjectivity and psychopharmaceutical use among heroin users with co-occurring mental illness.

Authors:  Allison V Schlosser; Lee D Hoffer
Journal:  Cult Med Psychiatry       Date:  2012-03

6.  "I Was Not Sick and I Didn't Need to Recover": Methadone Maintenance Treatment (MMT) as a Refuge from Criminalization.

Authors:  David Frank
Journal:  Subst Use Misuse       Date:  2017-07-13       Impact factor: 2.164

7.  Premature discharge from methadone treatment: patient perspectives.

Authors:  Heather Schacht Reisinger; Robert P Schwartz; Shannon Gwin Mitchell; James A Peterson; Sharon M Kelly; Kevin E O'Grady; Erica A Marrari; Barry S Brown; Michael H Agar
Journal:  J Psychoactive Drugs       Date:  2009-09

8.  With God's help i can do it: crack users? Formal and informal recovery experiences in El Salvador.

Authors:  Julia Dickson-Gomez; Gloria Bodnar; Carmen Eugenia Guevara; Karla Rodriguez; Lorena Rivas De Mendoza; A Michelle Corbett
Journal:  Subst Use Misuse       Date:  2010-08-24       Impact factor: 2.164

9.  Methadone treatment and HIV and hepatitis B and C risk reduction among injectors in the Seattle area.

Authors:  H Thiede; H Hagan; C S Murrill
Journal:  J Urban Health       Date:  2000-09       Impact factor: 3.671

10.  Buprenorphine substitution treatment in France: drug users' views of the doctor-user relationship.

Authors:  Anne Guichard; France Lert; Jean-Marc Brodeur; Lucie Richard
Journal:  Soc Sci Med       Date:  2007-04-17       Impact factor: 4.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.